ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2281

An Analysis Of Highly Discordant Erythrocyte Sedimentation and C Reactive Protein Levels In Rheumatoid Arthritis

Micha Abeles1, Manuel Gomez-Ramirez2 and Aryeh M. Abeles1, 1Div of Rheumatic Diseases, University of Connecticut Health Center, Farmington, CT, 2Zanvyl-Krieger Mind Brain Institute, Johns Hopkins University, Baltimore, MD

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: C-reactive protein (CRP) and rheumatoid arthritis (RA)

  • Tweet
  • Email
  • Print
Session Information

Title: Rheumatoid Arthritis-Clinical Aspects III: Outcome Measures, Socioeconomy, Screening, Biomarkers in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose: Discordance between the erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) exists in a significant minority of rheumatoid  arthritis (RA) patients. Interpretation of studies exploring the phenomenon is problematic for a number of reasons including: the dichotomization of continuous variables, failure to consider potential influence of none acute phase factors and common co-morbid conditions. To assess discordant values between the ESR and CRP we did a prospective case control study by establishing deciles of CRP and ESR values and evaluating the highest decile (i.e. the one having the most discrepant values).

Methods: Data on individual RA patients consecutively seen over a 6 month period were prospectively obtained. Serologic data included complete blood counts, albumin, liver and renal function, and serum protein electrophoresis. All co-morbid conditions and medications used were noted. Weight, sex, age, and length of time from diagnosis were recorded. The clinical disease activity index (CDAI) was used as a measure of disease activity. We established deciles and categorized participants into separate groups based on their ESR/CRP ratios (stratifying by ESR; age and gender were accounted for). The discordant group comprised participants with the top 10% elevated ESR and normal CRP values and vice versa. Each patient was matched to a non-discordant patient seen most closely to that visit and matched for age and sex (and when possible, weight). Data was consequently de-identified and evaluated. We computed between-subject (discordant vs. controls) univariate analyses of variance (ANOVA) on the above variables using age as a covariate.

Results: 251 individual RA patients were seen in the 6 month period. Of 26 patients meeting criteria 22 were in the high ESR normal CRP category. We elected not to include participants with high CRP normal ESR values because of low sample number (N = 4). Age, sex, ethnicity and weight were similar between groups, The most common co-morbid conditions included hypertension, gastric reflux disease and hyperlipidemia equally seen in each group. The only significant difference our data revealed was of hematocrit (p < 0.01), with the discordant group having significant lower mean values as compared to controls (36.30 vs. 40.15).The ANOVA failed to reveal an effect on CDAI (p > 0.05)

Conclusion: No previous study has looked at extreme discordance between CRP and ESR values in RA. We prospectively evaluated RA patients and compared those in the highest decile of discordance with matched controls (accounting for sex, weight, and ethnicity), analyzing multiple variables and found that aside from hematocrit values, there was no difference between groups.


Disclosure:

M. Abeles,
None;

M. Gomez-Ramirez,
None;

A. M. Abeles,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-analysis-of-highly-discordant-erythrocyte-sedimentation-and-c-reactive-protein-levels-in-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology